Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Critical Reviews in Oncology/Hematology|September 23, 2008
Current management of stage I testicular non-seminomatous germ cell tumoursD Pectasides, E Pectasides, A Constantinidou, et al.
Critical Reviews in Oncology/Hematology|December 3, 2008
Stage I testicular seminoma: management and controversiesD Pectasides, E Pectasides, A Constantinidou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
The pharmacological treatment of aggressive fibromatosis: a systematic reviewJ Janinis, M Patriki, L Vini, et al.
European Urology|January 1, 1990
Intravesical interferon alfa-2b administration in the treatment of superficial bladder tumorsA Kostakopoulos, C Deliveliotis, E Mavromanolakis, et al.
European Journal of Gynaecological Oncology|January 1, 1988
Monoclonal antibodies in ovarian tumor imagingS Fotiou, D Skarlos, A Tserkezoglou, et al.
The Journal of Urology|March 17, 2004
Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced bladder cancer: a study by the Hellenic Cooperative Oncology GroupA Bamias, Ch Deliveliotis, G Aravantinos, et al.
Oncology|April 15, 1999
Carboplatin, methotrexate and 5-fluorouracil in combination with medroxyprogesterone acetate (JMF-M) in the treatment of advanced or recurrent endometrial carcinoma: A Hellenic cooperative oncology group studyD Bafaloukos, G Aravantinos, G Samonis, et al.
Medical Oncology (Northwood, London, England)|June 29, 2000
Phase II study of temozolomide in patients with relapsing high grade glioma and poor performance statusJ Janinis, E Efstathiou, C Panopoulos, et al.
Cancer Biomarkers : Section a of Disease Markers|September 26, 2015
Association of CD133 polymorphisms and response to bevacizumab in patients with metastatic colorectal cancerG Aravantinos, A Isaakidou, T Karantanos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1997
5-Fluorouracil, interferon-alpha-2b and cisplatin (FAP) for advanced urothelial cancer. A phase II study. Hellenic Co-operative Oncology GroupP A Kosmidis, C Bacoyiannis, G Fountzilas, et al.
Pageof 9